» Subscribe Today!
More of what you want to know.
The Daily News
X

Forgot your password?
Skip Navigation LinksHome > Name & Property Search
Search results for 'Pfizer' | Search again
DeSoto Public Records:0
Shelby Public Records:83
Editorial:100
West Tennessee:0
Middle Tennessee:4
East Tennessee:0
Other:0

You must be a subscriber to see the full results of your search.

Please log in or subscribe below if you are not already a subscriber.

The Daily News subscribers get full access to more than 13 million names and addresses along with powerful search and download features. Get the business leads you need with powerful searches of public records and notices. Download listings into your spreadsheet or database.

Learn more about our services | Search again


Editorial Results (free)

1. Editorial: Not All PILOTs Should Be Cleared for Takeoff -

In our long civic discussion about tax incentives to boost economic development, an often-repeated refrain is that these incentives – specifically payment-in-lieu-of-taxes, aka PILOTs – should be strategic in nature.

2. Last Word: T.A. Talks Memphis, EDGE Debate and Politics, Lots of Politics -

Grizz season opener at the Forum Wednesday is a win over NOLA 103 – 91. And Tony Allen’s Grizz jersey is retired. The day before, Allen wrote a piece for The Players’ Tribune on the Memphis experience and it is just about the best thing that will happen to you all day. He just walks right off the court and into the soul of this place.

3. Amazon, Pfizer Approved for Tax Incentives -

Amazon was awarded a 15-year payment-in-lieu-of-taxes incentive by the Economic Development Growth Engine for Memphis and Shelby County at its Wednesday, Oct. 18, meeting, despite the online retailer’s proposed distribution center spurring a larger debate about the types of jobs the city should incentivize in the future.

4. Last Word: Bredesen's Note, Serious Sewer Talks and Protest Vs. Process -

Another lively week in state politics as former Tennessee Gov. Phil Bredesen says he is considering a run for the U.S. Senate seat Bob Corker is giving up. This came Monday in a note to the Associated Press in which Bredesen said he will make his decision quickly about an entry into the Democratic primary.

5. Amazon, Pfizer Seek Incentives for Projects -

While Memphis has been working to win the nod from Amazon in the company’s highly publicized decision on where it will put its second headquarters, the city is poised to get a major unrelated investment from the e-commerce giant.

6. Last Word: Tigers Make Top 25, Pfizer's Next Tax Break and Shepherds Creek -

The Tigers make the top 25 ESPN Power Rankings for college football with the Liberty Bowl victory Saturday over Navy 30 – 27. And Tigers coach Mike Norvell responds to the pre-game arrest of a player on a rape charge.

7. Pfizer Seeks Incentives to Retain Financial Services Operations in Memphis -

Admitting that its workforce in Memphis has been declining due to technology and business changes, pharmaceutical company Pfizer Inc. is seeking a 14-year payment-in-lieu-of-taxes incentive from the city and county to retain its finance and accounting operations in Memphis with a “stabilized” workforce of about 250 workers.

8. FDA: Drug Shortages Possible Due to Puerto Rico Power Outage -

The Food and Drug Administration on Friday warned that U.S. drug shortages are possible because power outages in Puerto Rico have stopped or limited production at many medicine factories there.

Nearly 10 percent of the medicines used by Americans, plus numerous medical devices, are made in Puerto Rico, which lost most electricity when it was hit hard by Hurricane Maria about two weeks ago.

9. Key Drug Sales Push Pfizer Profit Up 50 Percent -

Rising sales of most key drugs, lower one-time charges and reduced manufacturing costs helped drive Pfizer's second-quarter profit up 50 percent.

The top U.S. drugmaker beat Wall Street profit forecasts, tweaked its own 2017 forecast, and predicted numerous lucrative drugs will be approved over the next half-decade. Still, cheaper generic competition continues to gnaw away at Pfizer's revenue, which fell short of analyst expectations.

10. HealthChoice Promotes Henning To Director of Population Health -

Sarah Henning has been promoted to director of population health programs at HealthChoice. Henning previously served as manager of the department. In her new role, Henning is responsible for designing, implementing and managing population health and wellness initiatives and programs for the HealthChoice network.
She also collaborates with stakeholders to promote and support these programs and to ensure they meet the needs of the affected populations and adapt with the changing health care environment.

11. UTHSC Hosting Pharmaceutical Safety Conference -

The University of Tennessee Health Science Center is working toward playing a major role in the safety and quality of medical products and the global pharmaceutical supply chain.

Its latest step in that direction is the university’s designation as a Center of Excellence in global medical product quality and pharmaceutical supply chain security. That comes from the Asia Pacific Economic Cooperation, an international forum supporting economic growth in the Asia-Pacific region.

12. FDA Approves 2nd Near-Copy of Remicade for Immune Disorders -

Federal regulators on Friday approved another alternative version of Remicade, an expensive injected drug widely used for rheumatoid arthritis and other immune system disorders.

The U.S. Food and Drug Administration approved Renflexis, developed by Samsung Bioepis Co. of South Korea. Its U.S. partner, Merck & Co. of Kenilworth, New Jersey, will market Renflexis.

13. Overcoming Opioids: The Quest for Less-Addictive Drugs -

Tummy tucks really hurt. Doctors carve from hip to hip, slicing off skin, tightening muscles, tugging at innards. Patients often need strong painkillers for days or even weeks, but Mary Hernandez went home on just over-the-counter ibuprofen.

14. Drugmakers Pledge Restraint, But Prices Will Still Soar -

TRENTON, N.J. (AP) – Several big drugmakers are trying to quell the ongoing furor over high drug prices by revealing more information about their pricing and even pledging to keep a lid on increases.

15. Pfizer Fined for Hiking Epilepsy Drug Price 2,600 Pct in UK -

LONDON (AP) – British regulators fined U.S. drugmaker Pfizer and distributor Flynn Pharma a record 89.4 million pounds ($112.7 million) Wednesday for increasing the cost of an epilepsy drug by as much as 2,600 percent.

16. Wyatt Aiken, Accomplished Memphis Commercial Real Estate Broker, Dies -

Widely known and highly respected Memphis commercial real estate broker Wyatt Aiken died Friday morning after an extended illness.

Aiken was executive vice president/CEO of Cushman Wakefield-Commercial Advisors. Among his many professional achievements, Aiken served as president of the SIOR (Society of Industrial and Office Realtors) Memphis Chapter in 2007-2008.

17. Companies Set Monthly Record for Mergers, Acquisitions -

U.S. companies are cutting merger deals at a record pace even though antitrust regulators have moved to oppose several recent high-profile combinations.

So far this month, companies have agreed to mergers and acquisitions valued at more than $251 billion, financial-information provider Dealogic said late Friday. That surpasses the previous record of $240 billion in July 2015.

18. Last Word: FedEx Changes, The Blue Cross Exit and Armageddon -

Was that really autumn Monday or was the drop in humidity a prank to get the trees to drop their leaves?

The FedEx shareholder’s meeting Monday included some changes in the management chart at FedEx Corp. – more like some changes in the seating with one retirement by Mike Glenn, whose office is next to company founder Fred Smith.

19. Drugmaker Pfizer Decides Not to Break Up Business -

TRENTON, N.J. (AP) – Drug giant Pfizer says it won't split into two publicly traded companies, despite pressure from investors frustrated by its lagging stock price, ending years of Wall Street speculation over its strategy and future.

20. Last Word: Bearwater Progress, Defining Certainty and A Special Session After All -

The older couple have been spotted around town a lot taking in the nightlife.

Former President and First Lady Jimmy and Rosalynn Carter have been to The Lookout at the top of the Pyramid this week to take in a sunset on the river. They also found their way to Beale Street one night this week.

21. AstraZeneca to Sell Antibiotic Pills Business to Pfizer -

LONDON (AP) – Pharmaceutical company AstraZeneca plans to sell its antibiotic pills business to Pfizer in a deal that will be valued in excess of $1.5 billion when rights, royalties and other payments are included.

22. Rx Pizza: 1 Free Meal Can Sway Doctor Prescribing -

CHICAGO (AP) – As little as one free meal from a drug company can influence which medicines doctors prescribe for Medicare patients, according to a study using Medicare records and recently released data from the health care law's Open Payments program.

23. Allergan, Pfizer Call Off Proposed $160B Merger -

Top U.S. drugmaker Pfizer and Irish rival Allergan are charting independent futures after scrapping a record $160 billion deal torpedoed by new Treasury Department rules meant to block American companies from moving their corporate addresses overseas – on paper – to avoid U.S. taxes.

24. Pfizer, Allergan $160B Deal Forms World's Largest Drugmaker -

Pfizer and Allergan are joining in the biggest buyout of the year, a $160 billion stock deal that will create the world's largest drugmaker.

It's also the largest so-called inversion, where an American corporation combines with a company headquartered in a country with a lower corporate tax rate, saving potentially millions each year in U.S. taxes.

25. Pfizer, Allergan in Deal Talks to Create Drug Giant -

TRENTON, N.J. (AP) — Pfizer and Botox maker Allergan are discussing a potential deal that could be the biggest of 2015, a year marked by a rapid-fire pace of megadeals, particularly in health care.

26. Drug Execs Behind Female Libido Pill Have Run Afoul of FDA -

WASHINGTON (AP) – A small drugmaker from North Carolina may succeed next week where many of the world's largest pharmaceutical companies have failed: in winning approval for the first drug to boost women's sexual desire.

27. FDA Weighs Approval of First-in-Class Cholesterol Drug -

WASHINGTON (AP) – Federal health regulators said Friday that a highly-anticipated, experimental drug from Sanofi lowers bad cholesterol more than older drugs. But officials have questions about whether to approve the drug based on that measure alone or wait for additional study results.

28. New Meds Help Drugmakers Weather Strong Dollar, Other Issues -

Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges.

Pfizer Inc., Merck & Co. and Bristol-Myers Squibb Co., which reported first-quarter results Tuesday, all derive at least half their revenue from selling products overseas. Because they're purchased in local currencies, the strong dollar is depressing the sales' value.

29. Methodist Foundation Awarded $25,000 Grant -

Methodist Healthcare Foundation has been chosen as one of 23 grant recipients for the Avon-Pfizer Metastatic Breast Cancer Grants Program, “Identify-Amplify-Unify.”

Methodist’s $25,000 grant will be used by the West Cancer Center to develop and implement a program for women with metastatic breast cancer.

30. Imminent Danger -

The risk is real. And the evidence is in the charges of second-degree murder against the owner of New England Compounding Center Inc., and pharmacists and others employed by the company.

31. Qsource Awarded $700,000 for Vaccine Study -

Tennesseans put themselves at risk for pneumonia simply because they don’t get vaccinated, and pneumonia kills 1 out of 20 people who get it.

A new study headed by Qsource aims to understand the barriers to pneumococcal vaccination, how to better communicate its importance and identify motivating factors that influence behavioral change.

32. Qsource Awarded $700,000 for Vaccine Study -

Tennesseans put themselves at risk for pneumonia simply because they don’t get vaccinated, and pneumonia kills 1 out of 20 people who get it.

A new study headed by Qsource aims to understand the barriers to pneumococcal vaccination, how to better communicate its importance and identify motivating factors that influence behavioral change.

33. Events -

The Center City Revenue Finance Corp. will meet Tuesday, Jan. 13, at 9 a.m. in the Downtown Memphis Commission conference room, 114 N. Main St. Visit downtownmemphiscommission.com.

34. Events -

The Center City Revenue Finance Corp. will meet Tuesday, Jan. 13, at 9 a.m. in the Downtown Memphis Commission conference room, 114 N. Main St. Visit downtownmemphiscommission.com.

35. US, German Drugmakers Team Up on Cancer Medicines -

TRENTON, N.J. (AP) – Pfizer said Monday that it will partner with German drug and chemical maker Merck in developing potential cancer drugs in a hot new medication class that harnesses the body's immune system to fight cancer.

36. CBRE Picked to Manage Lenox Park Buildings -

CB Richard Ellis Memphis has been selected by Highbrook Investment Management to manage four buildings in the Lenox Park office complex, located at Tenn. 385 near Kirby Road.

The four 100,000-square-foot buildings are part of the seven that comprise the largest collection of Class A office space in Memphis. CBRE Memphis began management of buildings C, D, E and F on May 1. Since Highbrook purchased the four buildings in 2012, more than 50,000 square feet has been leased to companies including C.H. Robinson, W.M. Barr, Verso Paper and Metro PCS.

37. CBRE Picked to Manage Lenox Park Buildings -

CB Richard Ellis Memphis has been selected by Highbrook Investment Management to manage four buildings in the Lenox Park office complex, located at Tenn. 385 near Kirby Road.

The four 100,000-square-foot buildings are part of the seven that comprise the largest collection of Class A office space in Memphis. CBRE Memphis began management of buildings C, D, E and F on May 1. Since Highbrook purchased the four buildings in 2012, more than 50,000 square feet has been leased to companies including C.H. Robinson, W.M. Barr, Verso Paper and Metro PCS.

38. Obama Hosts CEOs Whose Firms are Investing in US -

WASHINGTON (AP) – It's the yin and the yang of the U.S. corporate climate.

At the White House, President Barack Obama played the role of business pitchman Tuesday, saluting executives whose companies have chosen to gain or expand their footprint in the United States.

39. AstraZeneca Rejects $119 Billion Offer From Pfizer -

LONDON (AP) – The board of AstraZeneca on Monday rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, a decision that caused a sharp slide in the U.K. company's share price as many investors think it effectively brings an end to the protracted and increasingly bitter takeover saga.

40. Panel Votes Down Heart Safety Claim for Naproxen -

SILVER SPRING, Md. (AP) – A majority of federal health experts said Tuesday that new research is not strong enough to conclude that naproxen, the pain reliever in Aleve and many other medications, is safer on the heart than rival drugs used by millions of Americans to treat arthritis and everyday aches and pains.

41. FDA Reconsiders Heart Safety of Common Pain Pills -

WASHINGTON (AP) – Federal health experts are taking a second look this week at the heart safety of pain medications used by millions of Americans to treat arthritis and other everyday aches and pains.

42. Merck, Partners to Jointly Test Hot Cancer Drug -

Merck & Co.'s hot experimental cancer drug, already closely watched by investors, got more attention Wednesday after the company announced new alliances with three other drugmakers to test it in combination with their drugs.

43. Obama Convening Export Panel at White House -

WASHINGTON (AP) – President Barack Obama says rising U.S. exports have been "one of the biggest bright spots" of the U.S. economy.

Obama in 2010 set a goal of doubling exports by 2015, but the country is not on track to meet that goal. However, Obama pointed out the United States now sells more goods overseas than ever before, and those sales have boosted the U.S. economy. Obama says "made in America" means something around the world.

44. Pfizer to Pay $491 Million to Resolve Drug Marketing Case -

The U.S. Justice Department said Tuesday that drugmaker Pfizer Inc. will pay almost $491 million to resolve an investigation into illegal marketing of the organ transplant drug Rapamune by a company Pfizer later acquired.

45. Screwpulp Aims to Make Publishing Simpler -

With a name like Screwpulp, it’s not hard to figure out how the founders of the startup feel about the current state of the publishing industry.

Screwpulp is one of six companies participating in Seed Hatchery, a tech-focused business accelerator for high-growth companies that wraps up its third season this month. Richard Billings is the founder of Screwpulp, which he and his team have built to help writers do an end run around traditional publishing outlets.

46. Archer-Malmo Grows Again With Lease Expansion -

Archer-malmo has inked an additional 3,000 square feet in the Cotton Exchange Building, bringing its total footprint in the historic 12-story Downtown tower to 41,277 square feet across six floors.

47. Storm Leads Companies to Postpone Earnings Reports -

NEW YORK (AP) – A number of major U.S. companies postponed quarterly earnings reports scheduled for Monday and Tuesday, as Hurricane Sandy barreled into the East Coast and caused the first unplanned shutdown of financial markets since 2001.

48. 10 Drugmakers Team Up to Improve Testing Process -

TRENTON, N.J. (AP) – Pharmaceutical industry heavyweights are teaming up to address a challenge that's long vexed drugmakers: how to improve the way experimental drugs are tested so they can get approved, and reach patients, faster.

49. New Coupons Aim to Keep People Off Generic Drugs -

TRENTON, N.J. (AP) – If brand-name prescription medicines cost you as little as generic pills, which would you choose? A few drugmakers are betting Americans will stick with the name they know.

50. Pfizer Pays $60 Million to Settle Bribery Charges -

WASHINGTON (AP) – Pfizer has agreed to pay the federal government $60 million to settle allegations that its employees bribed doctors and other foreign officials in Europe and Asia to win business and boost sales.

51. GlaxoSmithKline to Pay $3 Billion for Health Fraud -

WASHINGTON (AP) – GlaxoSmithKline LLC will pay $3 billion and plead guilty to promoting two popular drugs for unapproved uses and to failing to disclose important safety information on a third in the largest health care fraud settlement in U.S. history, the Justice Department said Monday.

52. Evans Joins MERI As Finance Director -

Devonya Evans has joined the Medical Education & Research Institute as director of finance. Evans, a licensed certified public accountant, will be responsible for heading MERI’s finance and information technology departments.

53. Irving Leads Research Co. Animal Cell Therapies -

Adam M. Irving is chief executive officer of San Diego-based Animal Cell Therapies Inc., a company that develops stem cell treatments to treat a variety of ailments for animals. Irving is based in Memphis.

54. Moody's: New Generics Will Aid Some Supermarkets -

NEW YORK (AP) – Moody's Investors Service said Wednesday that supermarkets with big pharmacy sections will get a small boost to their profits in 2012 as low-cost versions of some of the world's best-selling pharmaceuticals reach the market.

55. Plotting a Course -

State and federal officials are developing new programs and legislation to bolster small businesses.Many companies are facing a variety of hurdles in a lackluster economy in which millions remain jobless and the outlook for consumer confidence and companies’ confidence in hiring and investing remain bleak. But what shape those hurdles have taken depends on who you ask.

56. Health Care Stocks Endure Turmoil Better Than Most -

Health care stocks historically provide a relatively safe haven in roiling markets. They're less tethered to the economy's every movement than other stocks and tend to be less volatile.

Anxious investors might be considering putting money in the sector, but the current outlook is complicated by uncertainty over the government's changing involvement in health care. The wild card is potential cuts to Medicare or Medicaid, soon to be considered by Congress' new debt-reduction supercommittee.

57. Pfizer Ending Manufacturing at Bristol Plant -

BRISTOL, Tenn. (AP) – Pharmaceutical company Pfizer Global Supply is ending manufacturing and logistics operations at its Bristol, Tenn., facility, but the plant will continue its commercial and support operations.

58. Pfizer Q2 Net Up 5 Pct. on Lower Charges, Taxes -

Generic competition cut deeper into drugmaker Pfizer Inc.'s sales in the second quarter – with the U.S. patent expiration for its cholesterol fighter Lipitor, the world's top-selling drug, just five months away.

59. Lawsuit: Wyeth had Illegal Patents on Effexor -

JACKSON, Miss. (AP) – A federal lawsuit in Mississippi claims a major pharmaceutical company misrepresented clinical data and used sham litigation to maintain a monopoly over a drug used to treat depression and anxiety.

60. Pfizer to Trim 6,000 Jobs, Shut 8 Plants Worldwide -

NEW YORK (AP) - Pfizer Inc. reported Tuesday it will cut 6,000 jobs as it trims manufacturing capacity for health care products worldwide after acquiring smaller rival Wyeth last year.

61. ALL BUSINESS: Strong Dollar Hurts U.S. Exports -

NEW YORK (AP) - Ben Bernanke and Tim Geithner keep saying that they support a strong dollar. Now that we have it, they should eat their words.

The dollar has surged to an 8-month high against the euro, and is also rising against other major currencies. If it keeps strengthening, that could damage the already fragile U.S. economic recovery.

62. A Look at Fundraising in Tenn. Governor's Race -

NASHVILLE, Tenn. (AP) - Here is a breakdown of key fundraising details for the four main Republican and three main Democratic candidates for Tennessee governor.

___

Bill Gibbons:

63. Pfizer Posts Big Jump in Q4 Sales, Profit -

TRENTON, N.J. (AP) - Drugmaker Pfizer Inc., well into integrating its new Wyeth unit, posted a 34 percent jump in revenue Wednesday, but $3.2 billion in acquisition and restructuring charges and higher costs across the board weighed down profit.

64. Pressure Mounts to Stop Antibiotics in Agriculture -

FRANKENSTEIN, Mo. (AP) – The mystery started the day farmer Russ Kremer got between a jealous boar and a sow in heat.

The boar gored Kremer in the knee with a razor-sharp tusk. The burly pig farmer shrugged it off, figuring: “You pour the blood out of your boot and go on.”

65. Sanofi-Aventis to Buy Gold Bond Maker Chattem -

TRENTON, N.J. (AP) - French drugmaker Sanofi-Aventis SA said Monday it plans to buy the Chattanooga-based health-care company Chattem Inc., maker of over-the-counter mainstays like Gold Bond skin products, for $1.9 billion in cash.

66. Pfizer Inc. Receives Award For Worker Safety -

The Pfizer Inc. Memphis Logistics Center has received the Award of Excellence for Workplace Safety from Tennessee Department of Labor and Workforce Development Commissioner James Neeley.
The facility, which employs 200 people, qualified for the award by logging more than 512,000 hours without any lost time or injuries.
The award honors Tennessee employers and their workers who reach a required number of work hours without experiencing a lost workday case, and have maintained total injury and illness incident rates below the national average.

– Tom Wilemon

...

67. Vaccines on Horizon for AIDS, Alzheimer's, Herpes -

MARIETTA, Pa. (AP) - Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it.

68. Pfizer Trimming Research Plants after Buying Wyeth -

TRENTON, N.J. (AP) - Less than a month after buying Wyeth, drug giant Pfizer Inc. has mapped out a new structure for its research and development operations.

69. Merck, Now No. 2 Drugmaker, Set for Future Buys -

TRENTON, N.J. (AP) - The new Merck & Co. has become the world's second-biggest drugmaker overnight with a huge acquisition, but it still has a fat wallet and plans more wheeling and dealing.

70. Pfizer Q3 Profit Jumps 26 Percent on Cost-Cutting -

TRENTON, N.J. (AP) - Drugmaker Pfizer Inc. on Tuesday posted a 26 percent jump in third-quarter profit despite the recession, as sharp cost cuts made up for a dip in sales.

71. GlaxoSmithKline Changes Doctor Training Policy -

TRENTON, N.J. (AP) - British drugmaker GlaxoSmithKline PLC said Monday it is making major changes in its funding of educational programs for doctors, reducing the number it sponsors and switching its focus to independent ones with balanced information.

72. Sanofi Buys Merck's Half of Animal Health Business -

TRENTON, N.J. (AP) - French drugmaker Sanofi-Aventis SA has completed its $4 billion purchase of Merck & Co.'s half-interest in their veterinary medicine business, Merial Ltd., the companies said Friday.

73. Pfizer to Pay Record $2.3B Penalty over Promotions -

WASHINGTON (AP) - Federal prosecutors hit Pfizer Inc. with a record-breaking $2.3 billion in fines Wednesday and called the world's largest drug maker a repeating corporate cheat for illegal drug promotions that plied doctors with free golf, massages, and resort junkets.

74. Drugmaker Pfizer's Q2 Profit Plunges 19 Percent -

TRENTON, N.J. (AP) - Drug giant Pfizer Inc. on Wednesday said its second-quarter profit plunged 19 percent, as the strong dollar pulled down revenue, and higher taxes and costs for its pending purchase of rival Wyeth hurt the bottom line. Still, Pfizer raised its 2009 profit forecast slightly.

75. Drug Industry, Pfizer Lead in Health Lobbying -

WASHINGTON (AP) - The drug industry's trade group and one of the nation's biggest pharmaceutical companies reported spending more money than other health care organizations on lobbying in the second quarter of this year.

76. Wyeth Shareholders Vote to be Acquired by Pfizer -

Shareholders of drugmaker Wyeth on Monday voted overwhelmingly to be bought by industry giant Pfizer Inc., pushing aside one of the deal’s final hurdles.

77. FDA Requires Chantix, Zyban to Have Warning -

NEW YORK (AP) - The U.S. Food and Drug Administration will require two smoking-cessation drugs, Chantix and Zyban, to carry the agency's strongest safety warning over side effects including depression and suicidal thoughts.

78. Massey Keeps Tabs on Industrial Incentives -

Joann Massey started her new job just six months ago, but within that short time frame she has been a key player on a team that has made Memphis a better competitor for new jobs.

79. Dodd's Wife Serves on Health Care Company Boards -

WASHINGTON (AP) - The wife of a senator playing a lead role on a national health care overhaul sits on the boards of four health care companies, one of several examples of lawmakers with ties to the medical industry.

80. Drugmaker Wyeth Posts Flat 1st-Quarter Profit -

TRENTON, N.J. (AP) - Drugmaker Wyeth, which is being acquired by drug giant Pfizer, on Wednesday posted a flat first-quarter profit but beat analysts' expectations, as cost cuts offset lower revenue, particularly for its top seller, blockbuster antidepressant Effexor.

81. Pfizer Profit Dips 2 Percent, Sales Fall Much More -

TRENTON, N.J. (AP) - Pfizer Inc. posted a 2 percent drop in first-quarter profit Tuesday, as cost-cutting by the world's largest drugmaker couldn't offset big drops in sales for several medicines, especially a big drop for the cholesterol fighter Lipitor.

82. Glaxo Buys Stiefel Laboratories for $2.9 Billion -

LONDON (AP) - British drug maker GlaxoSmithKline PLC said Monday it will pay $2.9 billion to buy American dermatology business Stiefel Laboratories Inc. – the latest deal in a flurry of mergers and acquisitions in the pharmaceuticals industry.

83. Report: Pharma Deals in Q1 Exceed All 2008 Deals -

TRENTON, N.J. (AP) - The burst of drugmaker mergers announced in the first quarter is worth nearly 50 percent more than all the industry deals announced in 2008, according to a new report.

Deals in the quarter had a combined value of $166 billion, more than 10 times the value of deals announced in last year's first quarter and well over the $114 billion in deals announced in all of 2008.

84. Glaxo and Pfizer Create New HIV Drug Company -

TRENTON, N.J. (AP) - Pharmaceutical giants GlaxoSmithKline PLC and Pfizer Inc. will pool resources to create a new company to develop and sell HIV medicines, leveraging a small investment into the No. 2 market position.

85. Merck to Buy Schering-Plough -

The company that Abe Plough founded in Memphis no longer will bear his name under terms of a $41.1 billion merger announced Monday between Merck & Co. Inc. and Schering-Plough Corp.

86. Gov’t Says ‘Mass Layoffs’ Soared in January -

WASHINGTON (AP) – Employers took a large ax to their payrolls in January, the government said Wednesday, and the cuts are likely to get worse over the next few months.

The U.S. Labor Department reported that mass layoffs, or job cuts of 50 or more by a single employer, increased to 2,227 in January, up almost 50 percent from the same month last year. More than 235,000 workers were fired in last month’s cuts.

87. Medtronic To Disclose Physician Payments -

NEW YORK (AP) – Following years of pressure, medical device maker Medtronic Inc. will begin disclosing how much money it gives physicians in various consulting and other payments, though the reporting threshold is far less than currently proposed legislation.

88. 598K Job Cuts: Most Since ‘74 -

WASHINGTON (AP) – Recession-battered employers eliminated 598,000 jobs in January, the most since the end of 1974, and catapulted the unemployment rate to 7.6 percent. The grim figures were further proof that the nation’s job climate is deteriorating at an alarming clip with no end in sight.

89. New Jobless Claims Jump More Than Expected -

New jobless claims jumped far more than expected last week in an already dismal labor market, and there’s no relief in sight for workers as mass layoffs persist.

The U.S. Labor Department reported Thursday that the number of newly jobless workers seeking benefits rose last week to a seasonally adjusted 626,000, from the previous week’s upwardly revised figure of 591,000. The latest total is far more than analysts’ expectations of 583,000.

90. As Unemployment Rises, Uncle Sam Has Jobs -

WASHINGTON (AP) - The economic downturn has forced private industry and state and local government to shed jobs, but one major employer in the country is hiring: The federal government.

While the nation's 11 million unemployed and the millions more who fear losing their jobs may feel Washington should streamline too, economists say a strong federal work force is key to economic recovery. Were President Barack Obama to put any of the nearly 2 million federal civil servants out in the street in the middle of the worst economic downturn since the Great Depression, the consequences could be dire.

91. US Economy Shrinks at 3.8 Percent Pace -

WASHINGTON (AP) – The U.S. economy shrank at a 3.8 percent pace at the end of 2008, the worst showing in a quarter-century, as the deepening recession forced consumers and businesses to throttle back spending.

92. Mass Layoffs Surge in 2008 -

The number of layoffs involving 50 or more workers jumped by one-third last year, and the pace of large job cuts appears to have quickened in the first month of 2009.

The U.S. Labor Department reported Wednesday that 21,137 mass layoffs took place last year, up from 15,493 in 2007. That’s the highest annual total since 2001, the last time the economy was in recession, and the second highest since the department began tracking mass layoffs in 1995.

93. Fed Pledges to Use All Tools to Help Economy -

WASHINGTON (AP) - The Federal Reserve, acknowledging the economy has continued to deteriorate, signaled Wednesday that it will keep using unconventional tools to cushion the fallout, including keeping a key interest rate at a record low for quite "some time."

94. Pfizer to Buy Wyeth for $68B; Cut 8,000 Jobs -

TRENTON, N.J. (AP) - No. 1 drugmaker Pfizer Inc. said Monday it is buying No. 12 Wyeth for $68 billion in a deal that ultimately will wipe out nearly 20,000 jobs but quickly boost Pfizer's revenue and profit and transform it overnight into a medicine cabinet for all.

95. Job-Killing Recession Racks Up More Layoff Victims -

WASHINGTON (AP) - The recession is killing jobs at an alarming pace, with tens of thousands of new layoffs announced Monday by some of the biggest names in American business – Pfizer, Caterpillar and Home Depot.

96. Pfizer Pulls Bid For Over-the-Counter Viagra -

Pfizer has withdrawn its application to sell a 50-miligram dose of Viagra over the counter in Europe, but the company reported it still believes the dose is a suitable candidate for non-prescription supply. The European Medicines Medicinal Products for Human Use agency raised concerns about the proposal.

97. Renasant Names Wiegert VP, Mortgage Production Manager -

Michael Wiegert has been named vice president and mortgage production manager for Renasant Bank in Memphis.

98. Pfizer’s Memphis Center Receives STAR Award -

Tennessee Department of Labor & Workforce Development Commissioner James Neeley has announced that Pfizer Inc. – Memphis Logistics Center has received the Volunteer STAR award.

99. Report: US Drug Sales Growth Heads Toward New Low -

WASHINGTON (AP) - U.S. sales of pharmaceuticals will grow at the slowest rate on record this year, as the weakening economy compounds other factors hampering the industry, according to a report issued Wednesday.

100. $894 Million Deal Ends Pain of Pfizer's Lawsuits -

TRENTON, N.J. (AP) - Drug giant Pfizer Inc. has reached an $894 million deal to end most of the lawsuits over its two prescription pain relievers, the popular Celebrex and a similar drug, Bextra, no longer on the market.